Sign in
Enrolling by invitationPhase 4

Tests an oral antibiotic to help prevent joint infection after hip or knee replacement

Tests a 7-day antibiotic pill in adults at high risk of joint replacement infection.

Key facts

Who runs it
Mayo Clinic
Where
Iowa City and Rochester, United StatesSee the 2 sites
Trial code
Registry title
Antibiotic Prophylaxis in High-Risk Arthroplasty Patients
Status
Enrolling by invitation
Phase
Phase 4
People taking part
4,618 people, planned
Started
11 Jun 2020
Expected to end
Jan 2028
Type of study
Interventional, 2 groupsOne group gets an existing treatment, for comparison.
Treatments tested
  • Cephalexin
  • Doxycycline
  • Cefadroxil
Record updated
6 July 2026

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for adults planning a first hip or knee replacement who have a higher risk of joint infection. It tests a 7-day course of antibiotic tablets after surgery.

Age
18 to 99 years
Sex
All sexes can join.
Disease stage
Planned (elective) first total hip or total knee replacement, with at least one infection risk factor: BMI above 35 kg/m^2, diabetes, active smoking, chronic kidney disease, autoimmune disease, or nasal MRSA or MSSA colonization.
Earlier treatment
People with a history of Clostridium difficile colitis cannot join. People who cannot take antibiotics by mouth cannot join.
Biomarker or test result
Nasal colonization with MRSA or MSSA counts as one of the risk factors.

Main reasons for not taking part

  • Cannot take oral antibiotics
  • Allergy to the alternative antibiotics in the protocol
  • History of Clostridium difficile colitis
  • Revision, emergency, hemiarthroplasty or unicompartmental knee surgery
  • Pregnant

The registry criteria, word for word

Show all 18 criteriaShow less

Who can take part

  • Patient is a candidate for elective, primary total hip arthroplasties (THA) or total knee arthroplasties (TKA)
  • Patient is considered high-risk for developing Periprosthetic joint infections (PJI) based on having at least one of the following criteria:
  • Body mass index (BMI) > 35 kg/m\^2
  • Diagnosis of diabetes mellitus
  • Active tobacco smoker
  • Chronic kidney disease
  • Autoimmune disease
  • Nasal colonization with methicillin-resistant Staphylococcus aureus (MRSA) or methicillin-sensitive Staphylococcus aureus (MSSA)

Who cannot take part

  • Non-elective surgery
  • Allergy to antibiotic alternatives in the protocol
  • History of clostridium difficile colitis
  • Inability to consume oral antibiotics
  • Revision hip or knee arthroplasty procedure
  • Hemiarthroplasty
  • Unicompartmental knee arthroplasty
  • Simultaneous bilateral THA or TKA
  • Will have subsequent THA or TKA within 12 weeks of the index study procedure
  • Pregnant

Check if you might fit

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 18 and 99 years old?

Where in United States

  • University of Iowa Hospitals & ClinicsIowa City, United StatesEnrolling by invitation
  • Mayo ClinicRochester, United StatesEnrolling by invitation

About the trial

What the trial wants to find out

To determine the effectiveness of a 7-day course of an oral, prophylactic antibiotic on the incidence of periprosthetic joint infection and wound complications following primary total hip and knee arthroplasty in a high-risk patient population.

The 2 groups in the trial

  • Additional Antibiotic GroupExisting treatment, for comparison

    Patients will receive an oral antibiotic to be started after completion of standard perioperative antibiotics following primary hip or knee arthroplasty. Oral antibiotic will either be a first-generation cephalosporin (Cefadroxil or Cephalexin) or Doxycycline based upon patient allergies, kidney function and result of nasal colonization testing for MRSA.

    Treatment: Cephalexin, Doxycycline, and Cefadroxil

  • Control Group - No Additional AntibioticNo study treatment, for comparison

    Patients will receive standard perioperative antibiotics following primary hip or knee arthroplasty and no additional antibiotics.

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Antibiotic Prophylaxis in High-Risk Arthroplasty Patients
Plain-language title
Tests an oral antibiotic to help prevent joint infection after hip or knee replacementGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 12 November 2026.
Fit questions
Built from NCT04297592, who can take part
Record updated
6 July 2026